Clinical aspects of ifosfamide-induced encephalopathy

被引:0
|
作者
Weise, J [1 ]
Kohler, G [1 ]
Muller, J [1 ]
机构
[1] Univ Greifswald, Frauenheilkunde & Geburtshilfe Klin & Poliklin, D-17487 Greifswald, Germany
关键词
encephalopathy; ifosfamide; CNS-toxicity; chemotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the application of ifosfamide, one must be prepared for an ifosfamide-induced encephalopathy. The aim of our investigation was to determine the incidence of this side-effect and to describe its risk factors and the clinical management as well. Among 688 chemotherapy courses consisting of carboplatin and ifosfamide, we have observed an ifosfamide encephalopathy in 13 cases (1.89%) which was always associated with the risk factors alcohol anamnesis, hypalbuminemia, liver-or kidney dysfunction or a large tumor in the pelvis. Within the criteria of an intensive observation, the therapy consisted mainly of a forced diuresis in combination with a correction of the fluid and electrolyte balance. First experiences with the administration of methylene blue are reported. Using an ifosfamide dosage of 2 g/m(2) body surface area on day 1-3, and in consideration or exclusion of the above mentioned risk factors severe encephalopathies can be widely avoided.
引用
收藏
页码:129 / 132
页数:4
相关论文
共 50 条
  • [31] IFOSFAMIDE-INDUCED HYPERPIGMENTATION - REPLY
    TERESI, ME
    MURRY, DJ
    CORNELIUS, AS
    CANCER, 1994, 73 (01) : 241 - 241
  • [32] Ifosfamide-Induced Encephalopathy: A Case Report of a 15-Year-Old Patient
    Cherif Chefchaouni, A.
    Bechar, H.
    El Baraka, S.
    Mahdad, M.
    Nouibi, C.
    Belahcen, M. J.
    Rahali, Y.
    DRUG SAFETY, 2021, 44 (12) : 1456 - 1457
  • [33] Ifosfamide-Induced Tubuler Dysfunction
    Tokuc, G.
    Eker, N.
    Senay, E.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S171 - S171
  • [34] IFOSFAMIDE-INDUCED FANCONI SYNDROME
    GARCIA, AA
    ANNALS OF PHARMACOTHERAPY, 1995, 29 (06) : 590 - 591
  • [35] Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephalopathy
    Foxall, PJD
    Singer, JM
    Hartley, JM
    Neild, GH
    Lapsley, M
    Nicholson, JK
    Souhami, RL
    CLINICAL CANCER RESEARCH, 1997, 3 (09) : 1507 - 1518
  • [36] IFOSFAMIDE-INDUCED DIABETES INSIPIDUS
    Kabat, Brock
    Caster, Dawn
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 1) : S488 - S488
  • [37] Suspected ifosfamide-induced neurotoxicity
    McVay, JI
    Wood, AM
    PHARMACOTHERAPY, 1999, 19 (12): : 1450 - 1455
  • [38] HALLUCINATIONS AND IFOSFAMIDE-INDUCED NEUROTOXICITY
    DIMAGGIO, JR
    BROWN, R
    BAILE, WF
    SCHAPIRA, D
    CANCER, 1994, 73 (05) : 1509 - 1514
  • [39] IFOSFAMIDE-INDUCED FANCONI SYNDROME
    NEWBURYECOB, RA
    NOBLE, VW
    BARBOR, PRH
    LANCET, 1989, 1 (8650): : 1328 - 1328
  • [40] Ifosfamide-induced nephrotoxicity : Mechanism and prevention
    Nissim, I
    Horyn, O
    Nissim, I
    Daikhin, Y
    Luhovyy, B
    Yudkoff, M
    FASEB JOURNAL, 2006, 20 (05): : A893 - A893